Global Cardiovascular and Soft Tissue Repair Patches Market Report and Forecast 2024-2032

Global Cardiovascular and Soft Tissue Repair Patches Market Outlook

The global cardiovascular and soft tissue repair patches market size was valued at USD 4.54 billion in 2023. The market is being driven by the rising prevalence of cardiovascular and chronic diseases, development of the healthcare sector, and the increasing number of surgeries. The market is anticipated to grow at a CAGR of 8.2% during the forecast period 2024-2032 to reach a value of USD 9.24 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Market

Cardiovascular and soft tissue repair patches refer to various methods used by surgeons and doctors to treat the root cause of cardiovascular disease and repair the injured tissues. Soft tissue repair refers to the repair of muscle, blood vessels, fibrous tissue, and/or supporting connective tissues. Numerous biomaterials can be used in the repair and replacement of impaired tissues.

• The increasing collaborative activities among the established market players, pharmaceutical companies, and raw material suppliers for the development of novel technologies and innovative products using tissue engineered materials is a major trend in the cardiovascular and soft tissue repair patches market.

• Abdominal wall hernias are among the most common type of hernias found across all ages. The rising incidence of hernias, such as umbilical hernias, congenital diaphragmatic hernias, inguinal hernias, and ventral hernias, is anticipated to fuel the demand for cardiovascular and soft tissue repair patches.

• The growing geriatric population is a significant factor propelling the market for cardiovascular and soft tissue repair patches. This can be attributed to the fact that elderly people are prone to diseases related to the heart and stomach.

Opportunities and Challenges in the Market

There has been a rise in the number of cardiovascular cases and congenital heart diseases across the globe. Major players in the market are focusing on the acquisition of companies and collaboration with other players to propel research and development and bring innovations to the market. Governments of multiple countries have also started to promote collaborations and provide support to medical organisatons, which is likely to favour the cardiovascular and soft tissue repair patches market growth. 

However, the market can face some challenges in under developed regions due to a lack of awareness and misconceptions related to treatment methods. 

Global Cardiovascular and Soft Tissue Repair Patches Market Analysis

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on raw materials, the market can be segmented into ePTFE and biomaterial and tissue engineered materials, among others. Based on the application, it can be segmented into cardiac repair, vascular repair and reconstruction, pericardial repair, dural repair, and soft tissue repair. The regional markets for cardiovascular and soft tissue repair patches include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global cardiovascular and soft tissue repair patches market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans. 

• B. Braun SE

• LeMaitre Vascular, Inc

• Baxter

• CryoLife, Inc.

• CorMatrix, Inc.

• Glycar SA.

• W. L. Gore & Associates, Inc.

• Vascudyne, Inc.

• Others

Market Segmentation by Application

The soft tissue repair segment is estimated to witness a healthy growth in the coming years, accounting for a significant cardiovascular and soft tissue repair patches market share. There is a considerable increase in the incidences of hernias, including congenital diaphragmatic hernias, ventral hernias, umbilical hernias, and inguinal hernias, among others. With the increasing prevalence of hernias, the demand for tissue repair patches in therapeutic treatments is expected to rise, as this helps treat hernia disorders more effectively. 

Market Categorisation based on Raw Material

ePTFE is widely used as a raw material in the production of medical accessories such as dressings, ostomy bags, face masks, drainage bags, urine bags, and enclosures for medical devices, among others.

The ePTFE segment is likely to dominate the cardiovascular and soft tissue repair patches market. The rapid growth of the segment can be attributed to ePTFE's many advantages, including its high tensile strength, high durability, and ease of supply. 

Market Share by Region

North America holds a leading position and is expected to account for a significant revenue share of the cardiovascular and soft tissue repair patches market. The regional market growth is the result of evolving lifestyles, rising cases of cardiovascular disorders and other ailments due to increasing obesity rates, high level of alcohol consumption. 

Key product releases, a high concentration of market participants, and the presence of manufacturers in the US are some of the factors boosting the market growth in the region.

Meanwhile, due to the rising rates of cardiac diseases, rapid economic growth of nations such as China and India, and rising popularity of surgery methods that are minimally invasive, the Asia Pacific is projected to experience the fastest growth rate over the coming years. The Asian countries like China and India are likely to provide ample growth opoortunities for the market expansion due to the rapid development of the healthcare infrastructure, growing medical tourism, and increasing geriatric population in the countries. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

B. Braun SE is one of the world’s leading medical equipment manufacturing companies which aims to innovate the healthcare field to improve and protect the health of people around the world. The company has been active in the healthcare sector since 1839 and its headquarter is located in Melsungen, Germany. The company provides various solutions and systems such as trocar systems, ligation clips, light sources, anaesthetic tools, wound closure, blood glucose monitoring, insulin injection, and suction equipment.

LeMaitre Vascular, Inc. is a leading global innovator, manufacturer, and provider of treatment for peripheral vascular diseases that affect millions of people around the world. The company has a wide variety of products including Aortic, AV Access, Cardiac, Carotid, Lower Extremity, and Neuro, among others.

Baxter is a leading healthcare company whose main areas of focus include chronic and urgent medical issues, including kidney illness. The company’s portfolio of acute, nutritional, and hospital and surgical care products help improve healthcare services around the world. The firm specialises in several sectors, including pharmacy automation, anaesthesia, biosurgery, and medical devices.

Other cardiovascular and soft tissue repair patches market players include CryoLife, Inc., CorMatrix, Inc., Glycar SA., W. L. Gore & Associates, Inc., and Vascudyne, Inc., among others.

Key Highlights of the Report